Live Breaking News & Updates on Kate Beebe Devarney

Stay updated with breaking news from Kate beebe devarney. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Titan Pharmaceuticals Announces FDA Clearance of IND Application for Nalmefene Implant

/PRNewswire/ Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that the U.S. Food and Drug Administration ("FDA") has. ....

Stephen Kilmer , Kate Beebe Devarney , Titan Pharmaceuticals , National Institute For Drug Addiction , Titan Pharmaceuticals Inc , Securities Exchange , Drug Administration , Investigational New Drug , Opioid Use Disorder , Beebe Devarney , Chief Operating Officer , National Institute , Drug Addiction , South San Francisco , Securities Act , Securities Exchange Act ,

Titan Pharmaceuticals and MUSC FRD Enter Into Research and Option License Agreement

/PRNewswire/ Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) ("Titan" or the "Company") today announced that it has entered into a research and option license. ....

Stephen Kilmer , Scott Davis , Kate Beebe Devarney , Titan Pharmaceuticals , Titan Pharmaceuticals Inc , University Of South Carolina , Foundation For Research Development , Securities Exchange , Research Development , Medical University , South Carolina , Use Thereof , Chief Operating Officer , Innovation Support , Securities Act , Securities Exchange Act ,

Titan Pharmaceuticals and MUSC FRD Enter Into Research and Option License Agreement

Titan Pharmaceuticals and MUSC FRD Enter Into Research and Option License Agreement - read this article along with other careers information, tips and advice on BioSpace ....

Stephen Kilmer , Scott Davis , Kate Beebe Devarney , Titan Pharmaceuticals , Company Codes , Titan Pharmaceuticals Inc , University Of South Carolina , Foundation For Research Development , Securities Exchange , Research Development , Medical University , South Carolina , Use Thereof , Chief Operating Officer , Innovation Support , Securities Act , Securities Exchange Act , Itan Pharmaceuticals And Musc Frd Enter Into Research Option License Agreement ,

Titan Announces Positive Results from the First Studies of TP-2021 Implant in an Established Animal Model of Chronic Pruritus

Titan Announces Positive Results from the First Studies of TP-2021 Implant in an Established Animal Model of Chronic Pruritus
biospace.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospace.com Daily Mail and Mail on Sunday newspapers.

Stephen Kilmer , Marc Rubin , Charles Chavkin , Kate Beebe Devarney , National Institute On Drug Abuse , Department Of Pharmacology , University Of Washington Health Sciences Center , Titan Pharmaceuticals , Cara Therapeutics Inc , Company Codes , Titan Pharmaceuticals Inc , Pain Research , Securities Exchange , Cara Therapeutics , Phyllis Treuer Endowed Chair , Washington Health Sciences Center , Chief Operating Officer , Investigational New Drug , Executive Chairman , Opioid Use Disorder , National Institute , Drug Abuse , Securities Act , Securities Exchange Act , ஸ்டீபன் கில்மர் , மார்க் ரூபின் ,

Titan Announces Positive Results from the First Studies of TP-2021 Implant in an Established Animal Model of Chronic Pruritus

Titan Announces Positive Results from the First Studies of TP-2021 Implant in an Established Animal Model of Chronic Pruritus
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Stephen Kilmer , Marc Rubin , Charles Chavkin , Kate Beebe Devarney , National Institute On Drug Abuse , Department Of Pharmacology , University Of Washington Health Sciences Center , Titan Pharmaceuticals , Cara Therapeutics Inc , Titan Pharmaceuticals Inc , Pain Research , Securities Exchange , Cara Therapeutics , Phyllis Treuer Endowed Chair , Washington Health Sciences Center , Chief Operating Officer , Investigational New Drug , Executive Chairman , Opioid Use Disorder , National Institute , Drug Abuse , Securities Act , Securities Exchange Act , ஸ்டீபன் கில்மர் , மார்க் ரூபின் , சார்லஸ் சாவ்கின் ,